Cleocin and Livalo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cleocin (clindamycin phosphate) and Livalo (pitavastatin calcium). Common drug interactions include diarrhoea among females.

The phase IV clinical study analyzes what interactions people have when they take Cleocin and Livalo. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cleocin?

Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,940 Cleocin users. Check the latest studies of Cleocin.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.



On Jul, 04, 2026

11 people who take Cleocin and Livalo together, and have interactions are studied.

Cleocin and Livalo drug interactions.

What are the common drug interactions of Cleocin and Livalo, by gender? *:

female:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Respiratory disorder (respiratory disease)
  4. Sinusitis (inflammation of sinus)
  5. Weight increased
  6. Abdominal discomfort
  7. Alopecia areata (patchy baldness that typically begins with rapid hair loss)
  8. Drug hypersensitivity
  9. Fatigue (feeling of tiredness)
  10. Folliculitis (infection of hair root)

male:

n/a

What are the common drug interactions of Cleocin and Livalo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Nerve compression
  2. Oropharyngeal pain
  3. Pain
  4. Respiratory disorder (respiratory disease)
  5. Sinusitis (inflammation of sinus)
  6. Weight increased
  7. Abdominal discomfort
  8. Drug hypersensitivity
  9. Folliculitis (infection of hair root)
  10. Injection site bruising

60+:

  1. Alopecia areata (patchy baldness that typically begins with rapid hair loss)
  2. Fatigue (feeling of tiredness)
  3. Hair colour changes

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 81.82%
  2. Primary Immunodeficiency Syndrome: 2 people, 18.18%
  3. Breast Cancer Female: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Cleocin and Livalo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cleocin and Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cleocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cleocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Livalo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate and pitavastatin calcium (the active ingredients of Cleocin and Livalo, respectively), and Cleocin and Livalo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: